Mednet Logo
CommunityRheumatology

How do you approach the management of a patient with non-tophaceous gout who relapses upon withdrawal of acute gout prophylaxis despite adequate uric acid suppression on allopurinol?

Do you pursue further suppression of uric acid or resume prophylaxis, and if so, for how long?
2 Answers
Mednet Member
Mednet MemberInvited Expert
Rheumatology · National institues of Health
Answered on

The decision to initiate oral uric acid lowering therapy (ULT) is usually made when my patient has established a pattern of recurrent gout flares. Our discussion occurs during the flare, and the flare is treated. Depending on circumstances, the flare may be managed with colchicine, an NSAID, oral st...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Rheumatology · MetroHealth
Answered on

I agree with the comprehensive answer of Dr. @Dr. First Last, with the following additional comments: Patients with "non-tophacous gout" may include individuals with chronic MSU deposition that is difficult to clinically detect (except perhaps by ultrasound, DECT or appropriately-stained histopathol...

Join for free or sign in to see the full answer